Role of T Cells and Gamma Interferon during Induction of Hypersensitivity to Lipopolysaccharide by Toxic Shock Syndrome Toxin 1 in Mice
Open Access
- 1 March 2001
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (3), 1256-1264
- https://doi.org/10.1128/iai.69.3.1256-1264.2001
Abstract
The superantigenic function of toxic shock syndrome toxin 1 (TSST-1) is generally regarded as an important determinant of its lethal effects in humans or experimental animals. This study examined the role of superantigenicity in a BALB/c mouse model of lethal TSST-1-induced hypersensitivity to lipopolysaccharide (LPS). In this model, TSST-1 greatly potentiated both LPS-induced lethality, as well as LPS-induced serum tumor necrosis factor alpha (TNF-α) activity. Although BALB/c-SCID mice were resistant to these LPS enhancement effects of TSST-1, BALB/c-SCID mice reconstituted with T cells were completely susceptible to the enhancement effect of TSST-1 on LPS-induced serum TNF-α. Mice pretreated with cyclosporine (Cs) or neutralizing antibodies against gamma interferon (IFN-γ) did not develop lethal LPS hypersensitivity when injected with TSST-1, and these agents reduced the enhancement effect of TSST-1 on LPS-induced serum TNF-α by 99 and 85%, respectively. Cs pretreatment also completely inhibited the known capacity of TSST-1 to amplify LPS-induced levels of IFN-γ in serum. In contrast, mice given Cs after a priming injection of TSST-1, but before LPS, still exhibited lethal hypersensitivity to LPS. Cs given after TSST-1 also did not inhibit enhancement of LPS-induced serum TNF-α by TSST-1 but inhibited the enhancement effect of TSST-1 on LPS-induced serum IFN-γ by 50%. These experiments support the theory that TSST-1-induced hypersensitivity to LPS is mediated primarily by IFN-γ derived from superantigen-activated T cells.Keywords
This publication has 65 references indexed in Scilit:
- Protective effects of niacinamide in staphylococcal enterotoxin-B-induced toxicityToxicology, 1996
- Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.Journal of Clinical Investigation, 1994
- CD14: Cell surface receptor and differentiation markerImmunology Today, 1993
- Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal TransductionAnnual Review of Immunology, 1992
- Structure and Function of Lipopolysaccharide Binding ProteinScience, 1990
- Cyclosporine a inhibits TNF production without decreasing TNF mRNA levelsBiochemical and Biophysical Research Communications, 1989
- Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.Journal of Clinical Investigation, 1988
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987
- Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome.Journal of Clinical Investigation, 1984
- A PURIFIED GROUP A STREPTOCOCCAL PYROGENIC EXOTOXINThe Journal of Experimental Medicine, 1970